Functions and Advantages of PVP in Pharmaceutical Formulations

• Excipient: In the production of solid dosage forms such as tablets and capsules, PVP effectively aids in drug shaping, ensuring a more uniform and aesthetically pleasing appearance. It also helps achieve an even distribution of active ingredients within each unit dose, thereby improving product quality.
• Binder: During the preparation of granules and tablets, PVP can significantly enhance adhesion between drug powders, enabling higher strength and stability of the final products after tableting or granulation. This reduces the risk of damage during transportation and storage.
• Disintegrant: Once in the human digestive system, PVP can effectively promote the rapid dispersion and dissolution of tablets, accelerating the release of active ingredients and enabling the drug to take effect in a shorter time.
• Film-former: In oral thin film formulations or coated tablets, PVP can form a uniform and dense protective film on the surface, which not only improves drug stability but also enhances taste and swallowing comfort during administration.

• Low-molecular-weight PVP (e.g., K12, K17): Possesses excellent solubility, dissolving rapidly in aqueous or organic systems. It is particularly suitable for use in liquid formulations such as injections and eye drops, where high clarity and stability are essential, serving as a stabilizer and solubilizer.
• Medium-molecular-weight PVP (e.g., K25, K30): Strikes a good balance between solubility and binding strength, making it widely used in the production of tablets, capsules, granules, and other solid dosage forms. It is a common choice for pharmaceutical manufacturers.
• High-molecular-weight PVP (e.g., K90): Features longer molecular chains and higher viscosity, with outstanding film-forming and binding properties. It is often used in coating, sustained-release formulations, and other special dosage forms requiring high-viscosity solutions.

The pharmaceutical industry enforces strict quality control over raw materials and excipients. As a pharmaceutical excipient, PVP must comply with multiple pharmacopoeial standards, including the Chinese Pharmacopoeia, United States Pharmacopeia, and European Pharmacopoeia. These standards specify clear requirements for purity, loss on drying, pH value, residual monomers, and other indicators.

To ensure batch-to-batch stability and compliance, Hangzhou Witone Nano Materials Co., Ltd. has established a comprehensive and stringent quality management system. From the sourcing of raw materials to every stage of production and processing, and through to final product inspection and testing before release, the company implements full-process quality control to ensure that all PVP products consistently meet or exceed the quality standards and regulatory requirements of domestic and international customers.